Transferrin saturation with intravenous irons: An in vitro study

Coresh, 2001, Prevalence of high blood pressure and elevated serum creatinine level in the United States: Findings from the third National Health and Nutrition Examination Survey (1988–1994), Arch Intern Med, 161, 1207, 10.1001/archinte.161.9.1207 Hsu, 2002, Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: Results from the Third National Health and Nutrition Examination Survey, J Am Soc Nephrol, 13, 504, 10.1681/ASN.V132504 Nissenson, 1999, Iron deficiency in patients with renal failure, Kidney Int, 69, S18, 10.1046/j.1523-1755.1999.055Suppl.69018.x Besarab, 1999, An indistinct balance: The safety and efficacy of parenteral iron therapy, J Am Soc Nephrol, 10, 2029, 10.1681/ASN.V1092029 Agarwal, 2002, Issues related to iron replacement in chronic kidney disease, Semin Nephrol, 22, 479, 10.1053/snep.2002.35972 Sunder-plassMANN, 1999, Comparative look at intravenous iron agents: Pharmacology, efficacy, and safety of iron dextran, iron saccharate, and ferric gluconate, Semin Dialysis, 12, 243, 10.1046/j.1525-139X.1999.99030.x Himmelfarb, 2002, The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia, Kidney Int, 62, 1524, 10.1046/j.1523-1755.2002.00600.x Sengoelge, 2003, Impairment of transendothelial leukocyte migration by iron complexes, J Am Soc Nephrol, 14, 2639, 10.1097/01.ASN.0000087087.61306.4A Graham, 1976, Approaches to the standardization of serum unsaturated iron-binding capacity, J Lab Clin Med, 88, 477 Deiana, 2001, The effect of ferric-nitrilotriacetic acid on the profile of polyunsaturated fatty acids in the kidney and liver of rats, Toxicol Lett, 123, 125, 10.1016/S0378-4274(01)00372-1 Makey, 1976, The detection of four molecular forms of human transferrin during the iron binding process, Biochim Biophys Acta, 453, 250, 10.1016/0005-2795(76)90270-1 Esposito, 2002, Labile iron in parenteral iron formulations and its potential for generating plasma nontransferrin-bound iron in dialysis patients, Eur J Clin Invest, 32, 42, 10.1046/j.1365-2362.2002.0320s1042.x von bonsdorFF, 2002, Bleomycin-detectable iron assay for non-transferrin-bound iron in hematologic malignancies, Clin Chem, 48, 307, 10.1093/clinchem/48.2.307 Zager, 2002, Parenteral iron formulations: A comparative toxicologic analysis and mechanisms of cell injury, Am J Kidney Dis, 40, 90, 10.1053/ajkd.2002.33917 Parkkinen, 2000, Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration, Nephrol Dial Transplant, 15, 1827, 10.1093/ndt/15.11.1827 Tampo, 2003, Oxidative stress-induced iron signaling is responsible for peroxide-dependent oxidation of dichlorodihydrofluorescein in endothelial cells: Role of transferrin receptor-dependent iron uptake in apoptosis, Circ Res, 92, 56, 10.1161/01.RES.0000048195.15637.AC Rooyakkers, 2002, Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo, Eur J Clin Invest, 32, 9, 10.1046/j.1365-2362.2002.0320s1009.x Drueke, 2002, Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease, Circulation, 106, 2212, 10.1161/01.CIR.0000035250.66458.67